Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,000.66 +3.07 (+0.31%)
Streaming Delayed Price Updated: 10:30 AM EST, Dec 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
5 Bold Predictions for the Stock Market in 2026 ↗
Here are some things I think are more likely to happen in 2026 than the experts seem to believe. 
Via The Motley Fool
Topics Artificial Intelligence Economy
The 2025 Weight-Loss Drug Gold Rush: How Eli Lilly Pulled Ahead, Novo Hit A Snag — And A Swarm Of Biotech Underdogs Are Closing In ↗
Via Stocktwits
News headline image
2 Potential Stock Splits to Watch for in 2026 ↗
After experiencing incredible rallies during 2025, these two stocks could decide to "split it" in 2026. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Novo Nordisk Stock Was Melting on Monday ↗
It continues to be pounded by competition and challenges coming from numerous directions. 
Via The Motley Fool
Why Did Structure Therapeutics Stock Surge Pre-Market Today? ↗
Via Stocktwits
News headline image
Nasdaq, S&P 500 Futures Rise Ahead Of Fed Decision This Week: Why NFLX, CFLT, BA, LLY, IMMX Are On Traders' Radar ↗
Market-based odds now show an 87% chance of a rate cut. 
Via Stocktwits
Topics ETFs Economy Government
News headline image
Eli Lilly Scores Huge Win As China Adds Mounjaro To National Insurance — But Raises Fears Of A Brutal Pricing War ↗
Eli Lilly and Co (NYSE: LLY) announced that its diabetes drug, Mounjaro, will be added to China's state-run health insurance scheme from January 1, 2026. 
Via Benzinga
News headline image
Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip? ↗
This is no reason to panic. 
Via The Motley Fool
Topics Government
News headline image
ELI LILLY & CO (NYSE:LLY) Offers a High-Quality Dividend Backed by Strong Profitability and Growth ↗
Eli Lilly offers a stable, growing dividend backed by exceptional profitability and solid financial health, making it a prime pick for long-term dividend growth investors. 
Via Chartmill
News headline image
Do These 3 Healthcare Stocks Need a Checkup? ↗
These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk? 
Via The Motley Fool
Topics Intellectual Property
News headline image
Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028 ↗
Eli Lilly's stock price and market cap are poised to explode with the GLP-1 market. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
This Pharmaceutical Giant Fell by 10% After a Setback: Time to Sell the Stock? ↗
The issues are piling on for the healthcare leader, but this one is nowhere near insurmountable. 
Via The Motley Fool
News headline image
With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗
Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year. 
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
Trump Administration Eases Investment Deadlines For Large Pharma Companies: Report ↗
The report added that at least one of these companies expects to fulfill the multi-billion-dollar investment pledge in full by Jan. 1, 2029. 
Via Stocktwits
Topics Artificial Intelligence Government Workforce
News headline image
How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks?
Despite Agilent Technologies’ underperformance relative to its industry peers, Wall Street analysts remain moderately optimistic about the stock’s prospects. 
Via Barchart.com
News headline image
As Eli Lilly Cuts Zepbound Prices, Should You Buy, Sell, or Hold LLY Stock?
Eli Lilly has decided to slash prices of its weight loss drug Zepbound, making it more accessible to customers. 
Via Barchart.com
Topics World Trade
News headline image
1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year ↗
A key catalyst may be right around the corner. 
Via The Motley Fool
News headline image
Eli Lilly’s Jaypirca Granted Traditional FDA Approval In Treating Certain Cancers ↗
The agency approved the drug for patients who were previously treated with a covalent BTK inhibitor. 
Via Stocktwits
News headline image
My Top 5 Stocks to Buy Now in December (2025) ↗
There is something for everyone in this excellent list of stocks. 
Via The Motley Fool
News headline image
2 Trillion-Dollar Dividend Stocks to Buy and Hold for 10 Years ↗
They are capitalizing on their ability to innovate and rewarding loyal shareholders in the process. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Navellier Ups Energy Exposure, Increases Argan Position to Over $10 Million ↗
AI demand is making energy stocks attractive. 
Via The Motley Fool
Topics Artificial Intelligence Energy Regulatory Compliance
News headline image
The Shifting Tides: How Retail and Institutional Forces Reshape Market Dynamics
As of late 2025, the financial markets are in the midst of a profound transformation, driven by the dynamic and often divergent interplay between institutional behemoths and an increasingly empowered... 
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
News headline image
U.S. Stock Market Finds Its Footing: A Cautious Ascent After Tariff Shocks and AI Volatility
The U.S. stock market is currently navigating a period of cautious optimism, working to regain solid ground after a tumultuous year marked by significant losses in early 2025 and persistent concerns... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
If You Invested $100 In Eli Lilly Stock 5 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗
Via MarketBeat
News headline image
Fundstrat's Tom Lee Predicts S&P 500 Could Climb To 7,300 In December: Report ↗
Lee also cited the end of the Federal Reserve’s quantitative tightening program, effective December 1, as a tailwind for U.S. equity markets. 
Via Stocktwits
Topics Economy Stocks
News headline image
Eli Lilly Cuts Prices For Weight Loss Drug Zepbound To $299 A Month As It Takes On Novo Nordisk’s Wegovy ↗
Patients can buy Zepbound at these prices through the company’s direct-to-consumer platform, LillyDirect. 
Via Stocktwits
Topics Economy Government
News headline image
Trillion-Dollar Companies Now Go To 11; Google Is No. 3 ↗
Eli Lilly recently gained a trillion-dollar valuation. S&P 500 titans Nvidia leads 
Via Investor's Business Daily
Topics Stocks
News headline image
Novo Nordisk's Latest Clinical Result Is Sending the Stock Plunging. Here's What Investors Need to Know. ↗
A promising obesity and diabetes drug stumbles in Alzheimer's trials, rattling markets. Did investors overreact, or is this a reset for long-term opportunity? 
Via The Motley Fool
News headline image
Is the Vanguard Dividend Appreciation ETF a Buy Now? ↗
The Vanguard Dividend Appreciation ETF is a popular choice among dividend investors. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.